<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-8909</journal-id>
<journal-title><![CDATA[Medicina crítica (Colegio Mexicano de Medicina Crítica)]]></journal-title>
<abbrev-journal-title><![CDATA[Med. crít. (Col. Mex. Med. Crít.)]]></abbrev-journal-title>
<issn>2448-8909</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Medicina Crítica A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-89092024000700575</article-id>
<article-id pub-id-type="doi">10.35366/119530</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Lesión renal aguda y terapia de soporte renal lenta continua en la unidad de cuidados intensivos; una ventana de probabilidades en población mexicana; del arte a la realidad]]></article-title>
<article-title xml:lang="en"><![CDATA[Acute kidney injury and continuous slow renal support therapy in the intensive care unit; a window of probability in the Mexican population; from art to reality]]></article-title>
<article-title xml:lang="pt"><![CDATA[Lesão renal aguda e terapia de suporte renal lento contínuo na Unidade de Cuidados Intensivos; uma janela de probabilidade na população mexicana; da arte à realidade]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Correa Beaurregard]]></surname>
<given-names><![CDATA[Nancy Rubí]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López Fermín]]></surname>
<given-names><![CDATA[Jorge]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez Domínguez]]></surname>
<given-names><![CDATA[Karla Patricia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Luis Ruiz]]></surname>
<given-names><![CDATA[Miguel Ángel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado Hospital de alta especialidad ]]></institution>
<addr-line><![CDATA[Veracruz ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<volume>38</volume>
<numero>7</numero>
<fpage>575</fpage>
<lpage>580</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-89092024000700575&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-89092024000700575&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-89092024000700575&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: La lesión renal aguda es una afección frecuente en pacientes críticos, los cuales llegan a ameritar uso de terapia de reemplazo renal. La modalidad de prescripción sigue siendo un pilar fundamental por el costo-beneficio que implica. La prescripción de una modalidad de terapia de reemplazo aún no se esclarece en las indicaciones y criterios establecidos en la literatura (ELAIN, AKIKI, IDEAL ICU, STARRT AKI y AKIKI-2) para someter a pacientes con patologías críticas controversiales a terapias renales lentas continuas y comúnmente manipuladas a conveniencia en unidades de cuidados intensivos, incluso de forma empírica o influenciado por la industria. Al analizar esta problemática en la falta de congruencia en la toma de decisiones de nuestro centro hospitalario, se realizó un estudio local con el fin de obtener el desenlace de los pacientes que inician la terapia de reemplazo renal lenta continua en sus primeras horas de estancia en la unidad, observando una tasa de supervivencia sin un efecto clínico relevante. Considerando las limitaciones como la heterogeneidad de variables implicadas (severidad de la enfermedad condicionante, prescripción, modalidades, datos demográficos de la población estudiada) nuestro grupo de trabajo realizó el siguiente estudio con el fin de obtener líneas de investigación con datos de población del sureste mexicano.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Acute kidney injury is a frequent condition in critically ill patients, who may require renal replacement therapy. The prescription modality continues to be a fundamental pillar due to the cost-benefit involved. The prescription of a replacement therapy modality is still unclear in the indications and criteria established in the literature (ELAIN, AKIKI, IDEAL ICU, STARRT AKI and AKIKI-2) for subjecting patients with controversial critical pathologies to continuous and commonly manipulated slow renal therapies at convenience in intensive care units, even in an empirical or industry-influenced manner. In analyzing this problem in the lack of congruence in decision making in our hospital center, a local study was carried out in order to obtain the outcome of patients who initiate continuous slow renal replacement therapy in their first hours of stay in the unit, observing a survival rate without a relevant clinical effect. Considering the limitations such as the heterogeneity of the variables involved (severity of the conditioning disease, prescription, modalities, demographic data of the population studied), our working group conducted the following study in order to obtain lines of research with data from the population of southeastern Mexico.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo: A lesão renal aguda é uma condição comum em pacientes em estado crítico que podem necessitar de terapia de substituição renal. A modalidade de prescrição continua a ser um pilar fundamental da relação custo-benefício. A prescrição de uma modalidade de terapia de substituição ainda não é clara nas indicações e critérios estabelecidos na literatura (ELAIN, AKIKI, IDEAL ICU, STARRT AKI e AKIKI-2) para submeter os pacientes com patologia crítica controversa a terapias renais lentas contínuas e comumente manipuladas, de acordo com as conveniências das unidades de terapia intensiva, mesmo de forma empírica ou influenciada pela indústria. Ao analisar este problema de falta de congruência na tomada de decisões do nosso centro hospitalar, foi realizado um estudo local com o objetivo de obter a evolução dos pacientes que iniciam terapêutica renal substitutiva lenta contínua nas primeiras horas de internamento na unidade, observando-se uma taxa de sobrevivência sem efeito clínico relevante. Considerando as limitações como a heterogeneidade das variáveis envolvidas (gravidade da doença condicionante, prescrição, modalidades, dados demográficos da população estudada), o nosso grupo de trabalho realizou o seguinte estudo com o objetivo de obter linhas de investigação com dados da população do sudeste do México.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[lesión renal aguda]]></kwd>
<kwd lng="es"><![CDATA[terapia de reemplazo renal continua]]></kwd>
<kwd lng="es"><![CDATA[unidad de cuidados intensivos]]></kwd>
<kwd lng="es"><![CDATA[acidosis metabólica]]></kwd>
<kwd lng="en"><![CDATA[acute kidney injury]]></kwd>
<kwd lng="en"><![CDATA[continuous renal replacement therapy]]></kwd>
<kwd lng="en"><![CDATA[intensive care unit]]></kwd>
<kwd lng="en"><![CDATA[metabolic acidosis]]></kwd>
<kwd lng="pt"><![CDATA[lesão renal aguda]]></kwd>
<kwd lng="pt"><![CDATA[terapia de substituição renal contínua]]></kwd>
<kwd lng="pt"><![CDATA[unidade de terapia intensiva]]></kwd>
<kwd lng="pt"><![CDATA[acidose metabólica]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bagshaw]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Darmon]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ostermann]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury]]></article-title>
<source><![CDATA[Intensive Care Med]]></source>
<year>2017</year>
<volume>43</volume>
<page-range>841-54</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Correa]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Montero]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lesión renal aguda ¿Qué hay de nuevo en la evidencia?]]></article-title>
<source><![CDATA[RFS Revista Facultad de Salud]]></source>
<year>2023</year>
<page-range>99-113</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roesler]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Insuficiencia renal aguda en pacientes críticos]]></article-title>
<source><![CDATA[Revista Chilena de Urología]]></source>
<year>2016</year>
<volume>81</volume>
<page-range>20-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fuentes]]></surname>
<given-names><![CDATA[AV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Terapias de reemplazo renal agudo en pacientes críticos]]></article-title>
<source><![CDATA[Rev Med Clin Condes]]></source>
<year>2024</year>
<volume>35</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>14-21</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zarbock]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kellum]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Schmidt]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2016</year>
<volume>315</volume>
<numero>20</numero>
<issue>20</issue>
<page-range>2190</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaudry]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hajage]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Schortgen]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Initiation strategies for renal-replacement therapy in the intensive care unit]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2016</year>
<volume>375</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>122-33</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barbar]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Clere-Jehl]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bourredjem]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Timing of renal-replacement therapy in patients with acute kidney injury and sepsis]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2018</year>
<volume>379</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>1431-42</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<collab>STARRT-AKI Investigators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group</collab>
<article-title xml:lang=""><![CDATA[Timing of initiation of renal-replacement therapy in acute kidney injury]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2020</year>
<volume>383</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>240-51</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaudry]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hajage]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Martin-Lefevre]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2021</year>
<volume>397</volume>
<numero>10281</numero>
<issue>10281</issue>
<page-range>1293-300</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaudry]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Grolleau]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Barbar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2022</year>
<volume>26</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>93</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
